Here are the latest quarterly results of MARKSANS PHARMA.. For more details, see the MARKSANS PHARMA. financial fact sheet and MARKSANS PHARMA. share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 4,180 | 4,338 | 4,526 | 4,798 | 4,860 | 5,000 | 5,312 | 5,861 | |
Other income | Rs m | 153 | 165 | 142 | 177 | 110 | 101 | 190 | 48 | |
Turnover | Rs m | 4,334 | 4,503 | 4,667 | 4,975 | 4,970 | 5,101 | 5,502 | 5,909 | |
Expenses | Rs m | 3,544 | 3,609 | 3,723 | 4,032 | 3,764 | 3,981 | 4,173 | 4,531 | |
Gross profit | Rs m | 636 | 729 | 803 | 766 | 1,095 | 1,020 | 1,139 | 1,330 | |
Depreciation | Rs m | 214 | 111 | 141 | 127 | 139 | 137 | 176 | 220 | |
Interest | Rs m | 50 | 18 | 25 | 24 | 24 | 16 | 16 | 32 | |
Profit before tax | Rs m | 526 | 764 | 778 | 792 | 1,042 | 968 | 1,138 | 1,127 | |
Tax | Rs m | 229 | 163 | 177 | 169 | 215 | 264 | 299 | 297 | |
Profit after tax | Rs m | 297 | 602 | 601 | 623 | 827 | 704 | 839 | 830 | |
Gross profit margin | % | 15.2 | 16.8 | 17.7 | 16.0 | 22.5 | 20.4 | 21.4 | 22.7 | |
Effective tax rate | % | 43.6 | 21.3 | 22.8 | 21.3 | 20.6 | 27.3 | 26.3 | 26.4 | |
Net profit margin | % | 7.1 | 13.9 | 13.3 | 13.0 | 17.0 | 14.1 | 15.8 | 14.2 | |
Diluted EPS | Rs | 0.7 | 1.3 | 1.3 | 1.4 | 1.8 | 1.6 | 1.9 | 1.8 | |
Diluted EPS (TTM) | Rs | 4.1 | 4.1 | 4.4 | 4.7 | 5.9 | 6.1 | 6.6 | 7.1 | |
Subscriber Feature |
Asian share markets made a cautious start on Monday in a week where inflation figures could make or break hopes for earlier US rate cuts.